SARAH PERKINS: Open Payments
NPI 1942607130 · SENATOBIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167 in 9 payments from 7 companies in 2025. Trend: 2023 $252 · 2024 $413 · 2025 $167
Food & beverage: $167
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: MOUNJARO, FARXIGA, Kerendia, JARDIANCE, Dexcom G6 Transmitter, Veozah.
Industry payments across MS — which companies pay providers there.
